Philips CPAP Devices Lawsuits To Be Consolidated In An MDL

Philips CPAP Devices Lawsuits To Be Consolidated In An MDL

Introduction

A request to consolidate Philips CPAP machines lawsuits has been raised in the federal court post the FDA's issue to recall the devices considering the growing number of claims.

The lawsuits allege the devices were dangerous and contained defective PE-PUR foam, which resulted in health hazards to the users. It is also observed that the foam degrades over time, resulting in the release of black particles or toxic chemicals directly into the air pathway.

Eventually, Philips recalled around 3.5 million CPAP, BiPAP and ventilator breathing machines from the U.S. market and urged the users to prohibit the use of the devices. The toxic particles released by the foam in the devices are linked to causing severe respiratory problems and other health complications, including cancer.

The first plaintiff who filed the lawsuit against the device maker has requested the federal court to consolidate the similar lawsuits and claims in an MDL for a common outcome and fair hearing.

Another plaintiff who filed the lawsuit in the U.S. District Court for the Middle District of Georgia on July 2 alleged that he experienced disrupted respiratory system, cellular damage, and DNA damage, and got diagnosed with lung cancer in June 2021 due to the daily use of the device.

Currently, there are at least ten different lawsuits filed across five different U.S. District Courts nationwide. The experts state that the number of Philips CPAP Machine lawsuits is expected to grow in the coming weeks and months as millions of users have been affected.